These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 30955196)
21. Serum beta 2-microglobulin as a biomarker in inflammatory bowel disease. Yılmaz B; Köklü S; Yüksel O; Arslan S World J Gastroenterol; 2014 Aug; 20(31):10916-20. PubMed ID: 25152594 [TBL] [Abstract][Full Text] [Related]
22. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis. Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734 [TBL] [Abstract][Full Text] [Related]
23. Elevated serum levels of circulating immunoinflammation-related protein complexes are associated with cancer. Wang Y; Song G; Wang Y; Qiu L; Qin X; Liu H; Li F; Wang X; Li F; Guo S; Zhang Y; Li Z J Proteome Res; 2014 Feb; 13(2):710-9. PubMed ID: 24295561 [TBL] [Abstract][Full Text] [Related]
24. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease. Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893 [TBL] [Abstract][Full Text] [Related]
25. Serum galectins as potential biomarkers of inflammatory bowel diseases. Yu TB; Dodd S; Yu LG; Subramanian S PLoS One; 2020; 15(1):e0227306. PubMed ID: 31929564 [TBL] [Abstract][Full Text] [Related]
27. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases. Dawiskiba T; Deja S; Mulak A; Ząbek A; Jawień E; Pawełka D; Banasik M; Mastalerz-Migas A; Balcerzak W; Kaliszewski K; Skóra J; Barć P; Korta K; Pormańczuk K; Szyber P; Litarski A; Młynarz P World J Gastroenterol; 2014 Jan; 20(1):163-74. PubMed ID: 24415869 [TBL] [Abstract][Full Text] [Related]
28. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome. Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223 [TBL] [Abstract][Full Text] [Related]
29. Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children. Filimoniuk A; Blachnio-Zabielska A; Imierska M; Lebensztejn DM; Daniluk U Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708181 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease. Oruç N; Ozütemiz O; Osmanoğlu N; Ilter T Turk J Gastroenterol; 2009 Mar; 20(1):9-12. PubMed ID: 19330729 [TBL] [Abstract][Full Text] [Related]
31. Biochemical Modulators of Tight Junctions (TJs): Occludin, Claudin-2 and Zonulin as Biomarkers of Intestinal Barrier Leakage in the Diagnosis and Assessment of Inflammatory Bowel Disease Progression. Górecka A; Jura-Półtorak A; Koźma EM; Szeremeta A; Olczyk K; Komosińska-Vassev K Molecules; 2024 Sep; 29(19):. PubMed ID: 39407507 [TBL] [Abstract][Full Text] [Related]
32. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Reese GE; Constantinides VA; Simillis C; Darzi AW; Orchard TR; Fazio VW; Tekkis PP Am J Gastroenterol; 2006 Oct; 101(10):2410-22. PubMed ID: 16952282 [TBL] [Abstract][Full Text] [Related]
33. Growth differentiation factor-15 serum concentrations reflect disease severity and anemia in patients with inflammatory bowel disease. Tonkic A; Kumric M; Akrapovic Olic I; Rusic D; Zivkovic PM; Supe Domic D; Sundov Z; Males I; Bozic J World J Gastroenterol; 2024 Apr; 30(13):1899-1910. PubMed ID: 38659482 [TBL] [Abstract][Full Text] [Related]
34. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location. Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427 [TBL] [Abstract][Full Text] [Related]
35. Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis. Herrlinger KR; Dittmann R; Weitz G; Wehkamp J; Ludwig D; Schwab M; Stange EF; Fellermann K Inflamm Bowel Dis; 2004 May; 10(3):229-33. PubMed ID: 15290916 [TBL] [Abstract][Full Text] [Related]
36. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course. Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876 [TBL] [Abstract][Full Text] [Related]
37. Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study. Zissimopoulos A; Vradelis S; Konialis M; Chadolias D; Bampali A; Constantinidis T; Efremidou E; Kouklakis G Scand J Gastroenterol; 2014 Aug; 49(8):942-9. PubMed ID: 24897131 [TBL] [Abstract][Full Text] [Related]
38. Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases. Ananthakrishnan AN; Cheng SC; Cai T; Cagan A; Gainer VS; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1342-8.e1. PubMed ID: 24407106 [TBL] [Abstract][Full Text] [Related]
39. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Solem CA; Loftus EV; Tremaine WJ; Harmsen WS; Zinsmeister AR; Sandborn WJ Inflamm Bowel Dis; 2005 Aug; 11(8):707-12. PubMed ID: 16043984 [TBL] [Abstract][Full Text] [Related]
40. Decreased serum fetuin-A levels and active inflammatory bowel disease. Ma P; Feng YC Am J Med Sci; 2014 Jul; 348(1):47-51. PubMed ID: 24487480 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]